HTFL

46.6904.62%
CM

Casey M. Tansey

Independent Director

Mr. Casey M. Tansey serves as Director of HeartFlow Holding, Inc. He has been a General Partner of U.S. Venture Partners Management Company, LLC since joining on April 29, 2005. Mr. Tansey has been a Director at Luminopia, Inc. since June 2023, an Independent Director of Shoulder Innovations, Inc. since October 2020, NeoChord, Inc since November 2018, ShiraTronics, Inc. since October 24, 2019, Neuros Medical, Inc. since August 7, 2017, Mobia Medical, Inc. (formerly known as MicroTransponder, Inc.) since June 2022 and Intuity Medical, Inc. since August 2006. He was Director at Inspire Medical Systems, Inc. since January 2008 until July 30, 2026. He serves as Director of Iantrek, Inc. He serves as a Director at PlaceIQ, Inc. and Nanostim, Inc. (sold to St. Jude Medical), Highlife SAS, CardioKinetix, IntersectENT, AtheroMed, ApniCure, Nanostim, ReShape Medical Inc. Standard Bariatrics, Inc., Dstillery and Highlife Medical. He is Independent Director of HeartFlow, Inc. since August 2010. He specializes in early-stage investments in medical device technologies and biopharmaceuticals. Tansey has many years of operating experience. He is a veteran of the medical device industry. Mr. Tansey served as an Interim Chief Executive Officer at SentreHEART, Inc. He is an Investment Advisor at Medical Technology Venture Partners and General Partner at U.S. Venture Partners. He served as the Chairman of Intuity Medical, Inc. and serves as the Chairman at CardioKinetix, Inc. Mr. Tansey served as the President and Chief Executive Officer at Epicor Medical, Inc. from September 2001 to December 2004. Prior to that, Mr. Tansey served as the Heartport's President and Chief Operating Officer from June 1999 to September 1999, a Senior Vice President of Sales and Marketing from January 1998 to June 1999, a Vice President of Sales and Marketing from December 1995 to January 1998, Chief Executive Officer and Director. From 1988 to joining Heartport Inc. in 1995, he served in various capacities at the Baxter Edward's Cardiovascular Division for nearly ten years, holding various Sales and Marketing positions. During his tenure at Baxter, Mr. Tansey was involved in launching innovative heart valve products. His most recent position at Baxter/Edwards was a Vice President of North American Sales. He also served as the Chief Executive Officer and President at Baxter Healthcare Corporation. Prior to this, Mr. Tansey held Sales positions at Nestle. He served as the Chief Executive Officer and President at Ethicon, Inc. Mr. Tansey served as the Chairman at SentreHEART, Inc. until May 25, 2016 and serves as its Director. Mr. Tansey served as a Director of Devax Inc. since November 2, 2005. He served as a Director of Heartport, Inc. since September 1999, Baxter Healthcare Corporation, Ethicon, Inc. and Epicor Medical. He served as an Independent Director of Intersect ENT, Inc. since March 2006 until August 2, 2017. Mr. Tansey served as the Chairman of the Board of Directors of the World Heart Foundation. Mr. Tansey holds an M.B.A. in Business and a B.S. from the College of Notre Dame De Namur University.

公司職務